logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Thorsten Fuereder

Medical University of Vienna
H指数:30
被引数:9,880

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes

接受免疫检查点抑制剂与化疗的癌症患者血浆蛋白质组谱的显著变化：对血栓风险和不良结局的启示

Research and Practice in Thrombosis and Haemostasis
IF3.4
2026-08-270
OAAI
Eleonora Camilleri; Nikola Vladic; Cornelia Englisch; Daniel Steiner; Matthias Preusser; Anna S. Berghoff; Thorsten Fuereder; Julia M. Berger; L. Renee Ruhaak; Suzanne C. Cannegieter; Bart J.M. van Vlijmen; Frederikus A. Klok; Cihan Ay
HER2-directed therapy is associated with an increased rate of cardiologic emergency department visits in real-world breast cancer patients.

HER2靶向治疗与真实世界中乳腺癌患者心血管急诊就诊率增加相关。

The Breast
IF0
2026-08-010
OAAI
Sandra Mayer; Anna Pfarrhofer; Sophie M. Neubauer; Sabina Pasalic; Georg Jeryczynski; Maximilian Marhold; Gerwin Heller; Jutta Bergler-Klein; Andreas Spannbauer; Thorsten Fuereder; Filippo Cacioppo; Anton Laggner; Matthias Preusser; Rupert Bartsch; Christoph Minichsdorfer
Real-world evidence from a tertiary academic center: clinical characteristics, microbiology and outcomes of oncology patients with febrile neutropenia presenting to the emergency department

来自三级学术中心的真实世界证据：急诊科就诊的肿瘤患者发热性中性粒细胞减少症的临床特征、微生物学和结局

BMC Infectious Diseases
IF3
2026-05-270
OAAI
Markus Kleinberger; Petar Popov; Anna Pfarrhofer; Sabina Pasalic; Sandra Mayer; Daniel Kogler; Filippo Cacioppo; Thorsten Fuereder; Markus Raderer; Thomas Brodowicz; Rupert Bartsch; Gerald Prager; Matthias Preusser; Christoph Minichsdorfer
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial

帕他妥昔德鲁克特肯（HER3-DXd）在活动性脑转移的乳腺癌患者中的应用（TUXEDO-3）：一项多中心、单臂、II期临床试验

The Lancet Oncology
IF0
2025-10-270
PRE
Rupert Bartsch; Maximilian Marhold; Javier Garde-Noguera; María Gion; Manuel Ruiz-Borrego; Richard Greil; María Valero; Antonio Llombart-Cussac; Juan José García-Mosquera; Miriam Arumi; Javier Cortés; Marta Campolier; José Antonio Guerrero; Felipe Slebe; Elena Martínez-García; Carlos Jiménez-Cortegana; Marta Vaz-Batista; Felicitas Oberndorfer; Julia Furtner; Thorsten Fuereder; Anna Sophie Berghoff; Matthias Preusser
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial

帕他单抗德鲁克替康（HER3-DXd）在活动性脑转移的非小细胞肺癌患者中的应用（TUXEDO-3）：一项多中心、单臂、II期临床试验

The Lancet Oncology
IF0
2025-10-270
PRE
Thorsten Fuereder; Javier Garde-Noguera; Juan José García-Mosquera; Manuel Ruiz-Borrego; María Valero; Antonio Llombart-Cussac; María Gion; Richard Greil; Miriam Arumi; Marta Campolier; José Antonio Guerrero; Giulia Raimondi; Mario Mancino; Carlos Jiménez-Cortegana; Marta Vaz-Batista; Felicitas Oberndorfer; Maximilian Marhold; Anna Sophie Berghoff; Julia Furtner; Rupert Bartsch; Matthias Preusser
Longitudinal Dynamics of Haemostatic Biomarkers in Patients with Cancer Receiving Immune Checkpoint Inhibitors versus Chemotherapy – Results from the CAT-BLED

癌症患者接受免疫检查点抑制剂与化疗时止血生物标志物的纵向动力学比较——CAT-BLED研究的结果

Research and Practice in Thrombosis and Haemostasis
IF3.4
2025-06-010
OA
Nikola Vladic; Cornelia Englisch; Julia Maria Berger; Florian Moik; Hubert Hayden; Johannes Thaler; Anna Sophie Berghoff; Thorsten Fuereder; Matthias Preusser; Ingrid Pabinger; Cihan Ay
A randomised phase II study to evaluate the efficacy and safety of androgen deprivation therapy (ADT) vs chemotherapy (CT) in patients with recurrent and/or metastatic, androgen receptor (AR) expressing, salivary gland cancers

一项随机Ⅱ期研究，旨在评估雄激素剥夺疗法（ADT）与化疗（CT）在复发性/转移性、雄激素受体（AR）阳性表达、涎腺癌患者中的疗效和安全性。

ANNALS OF ONCOLOGY
IF65.4
2024-09-013
PRE
Licitra, L. F. L.; Locati, L. D.; Digue, L.; Even, C.; Psyrri, A.; Clement, P. M.; Ochsenreither, S.; Delord, J-P.; Moro, C.; Machiels, J-P.; Fuereder, T.; Govaerts, A-S.; Quattrone, P.; De Cecco, L.; Perrone, F.; Rasschaert, M.; Nzokirantevye, A.; Joaquim, A.; Venslovaite, E.; Lefevre, C. Fortpied
Paclitaxel plus cetuximab for the treatment of recurrent and/or metastatic head and neck cancer after first-line checkpoint inhibitor failure: Primary analysis from the pace ace trial

帕利妥珠单抗联合西妥昔单抗用于一线免疫检查点抑制剂失败后的复发性和/或转移性头颈癌治疗：PACE ACE试验的初步分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-012
PRE
Fuereder, T.; Klinghammer, K.; Hahn, D. A.; Gruenberger, B.; Melchardt, T.; Greil, R.; Kocher, F.; Gamerith, G.; Wagner, C.; Berchtold, L.; Burian, M.; Strobl, A.
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases

曲妥珠单抗-deruxtecan治疗活动性脑转移的HER2-positive乳腺癌患者的II期TUXEDO-1试验的最终结果分析

NEURO-ONCOLOGY
IF13.4
2024-07-048
OAAI
Bartsch, Rupert; Berghoff, Anna Sophie; Furtner, Julia; Marhold, Maximilian; Bergen, Elisabeth Sophie; Roider-Schur, Sophie; Mair, Maximilian Johannes; Starzer, Angelika Martina; Forstner, Heidrun; Rottenmanner, Beate; Aretin, Marie-Bernadette; Dieckmann, Karin; Bago-Horvath, Zsuzsanna; Haslacher, Helmuth; Widhalm, Georg; Ilhan-Mutlu, Ayseguel; Minichsdorfer, Christoph; Fuereder, Thorsten; Szekeres, Thomas; Oehler, Leopold; Gruenberger, Birgit; Pfeiler, Georg; Singer, Christian; Weltermann, Ansgar; Berchtold, Luzia; Preusser, Matthias
FINAL OUTCOME ANALYSIS FROM THE PHASE II TUXEDO-1 TRIAL OF TRASTUZUMAB-DERUXTECAN IN HER2-POSITIVE BREAST CANCER PATIENTS WITH ACTIVE BRAIN METASTASES
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Bartsch, Rupert; Berghoff, Anna Sophie; Furtner, Julia; Marhold, Maximilian; Bergen, Elisabeth Sophie; Roider-Schur, Sophie; Starzer, Angelika Maria; Mair, Maximilian; Forstner, Heidrun; Rottenmanner, Beate; Aretin, Marie-Bernadette; Dieckmann, Karin; Bago-Horvath, Zsuzsanna; Haslacher, Helmuth; Widhalm, Georg; Ilhan-Mutlu, Aysegul; Minichsdorfer, Christoph; Fuereder, Thorsten; Szekeres, Thomas; Oehler, Leopold; Gruenberger, Birgit; Pfeiler, Georg; Singer, Christian F.; Weltermann, Ansgar; Berchtold, Luzia; Preusser, Matthias
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial
FRONTIERS IN ONCOLOGY
IF3.3
2024-01-040
OAAI
Cavalieri, Stefano; Bruno, Eleonora; Serafini, Mara Serena; Lenoci, Deborah; Canevari, Silvana; Lopez-Perez, Laura; Hernandez, Liss; Mariani, Luigi; Miceli, Rosalba; Gavazzi, Cecilia; Pasanisi, Patrizia; Rosso, Elena; Cordero, Francesca; Bossi, Paolo; Golusinski, Wojciech; Dietz, Andreas; Strojan, Primoz; Fuereder, Thorsten; De Cecco, Loris; Licitra, Lisa
Metabolic tumor volume and sites of organ involvement predict outcome in NSCLC immune-checkpoint inhibitor therapy
EUROPEAN JOURNAL OF RADIOLOGY
IF3.3
2024-01-010
OAAI
Kifjak, Daria; Hochmair, Maximilian; Sobotka, Daniel; Haug, Alexander R.; Ambros, Raphael; Prayer, Florian; Heidinger, Benedikt H.; Roehrich, Sebastian; Milos, Ruxandra-Iulia; Wadsak, Wolfgang; Fuereder, Thorsten; Krenbek, Dagmar; Fazekas, Andreas; Meilinger, Michael; Mayerhoefer, Marius E.; Langs, Georg; Herold, Christian; Prosch, Helmut; Beer, Lucian

研究方向

暂未获取到该数据
M
Matthias Preusser
H 指数:96论文数:1,142被引数:4.4万
R
Rupert Bartsch
H 指数:53论文数:635被引数:1.1万
C
Christoph Minichsdorfer
H 指数:15论文数:78被引数:1,018
A
Anna S. Berghoff
H 指数:58论文数:849被引数:1.4万
M
Maximilian Marhold
H 指数:18论文数:109被引数:1,568
M
Markus Raderer
H 指数:68论文数:478被引数:1.8万
J
Julia Furtner
H 指数:36论文数:279被引数:4,863
G
Gerald W. Prager
H 指数:44论文数:393被引数:6,765
D
Daniel Cejka
H 指数:26论文数:124被引数:2,698
C
Christian F. Singer
H 指数:72论文数:693被引数:2.1万